Adolor Corp (ADLR)

[mlkrborn]

"Cubist Pharmaceuticals Inc. agreed to acquire biopharmaceutical company Adolor Corp. for about $190 million in cash, adding two late-stage compounds to its pipeline. Cubist will pay $4.25 a share in cash, and agreed to make an additional contingent payment of up to $4.25 a share for certain milestones related to Adolor’s ADL5945, a potential treatment for chronic opioid induced constipation. Shares of Adolor surged 137% to $4.55 premarket."
source: WSJ oct 24 2011